Finance

Immuneering Shares Decline Amidst Phase 2a Clinical Trial Data Release

Updated atebimetinib Phase 2a results in pancreatic cancer contrast with chemotherapy outcomes, prompting stock sell-off

Immuneering Corporation's stock fell sharply after announcing new data from its Phase 2a trial evaluating atebimetinib combined with a modified chemot...

Zcash Faces Turmoil After Mass Developer Exit and Price Collapse

Entire Development Team Steps Down Amid Governance Dispute, Sparking 16% Price Drop

Zcash (ZEC) experienced a sharp 16% decline in its token price following the unexpected resignation of the entire Electric Coin Company (ECC) developm...

Alumis Inc. Expands Capital Raise in Support of Immune Disease Therapeutic Programs

Biotech shares see modest premarket gains as analysts increase price targets amid $300 million equity offering

Alumis Inc. has initiated a significant equity offering, aiming to generate approximately $300 million to support its pipeline of precision medicines ...

Nvidia Implements Stricter Terms on AI Chip Sales to China Amid Regulatory Complexity

New payment and compliance requirements shift regulatory exposure to buyers as China moves to approve limited H200 imports

Nvidia Corp is adjusting the sales framework for its advanced H200 AI chips destined for China, requiring upfront full payments and introducing string...

Phathom Pharmaceuticals Updates Q4 and Full-Year 2025 Financial Outlook Amid Ongoing Product Progress

Vonoprazan Prescription Growth and Phase 2 Trial Initiation Mark Key Developments as Company Plans Further Capital Raise

Phathom Pharmaceuticals Inc. recently released preliminary financial data for the fourth quarter and full year 2025, signaling slight revenue growth a...

Market Insights: Final Trade Picks Highlight Palo Alto Networks, Capital One, IDEXX Laboratories, and XLB ETF

Analysts and Investment Experts Identify Key Opportunities and Ratings Updates for Four Major Stocks and ETF

Market watchers and investment authorities have spotlighted several significant investment options during a recent investment forum, emphasizing Palo ...

JPMorgan's Q4 Earnings Preview: Dividend Strategy to Generate Steady Income

Analyzing how investors might leverage JPMorgan's dividend yield for monthly income ahead of upcoming earnings release

JPMorgan Chase & Co. is set to announce its fourth quarter earnings before market open on January 13, 2025, with expectations for higher earnings and ...

US Oil Majors Demand Concrete Assurances from Trump Administration Prior to Venezuelan Investment

Chevron and ConocoPhillips Seek Legal and Financial Protections Amid Uncertain Venezuelan Energy Landscape

Major American oil corporations are pressing the U.S. government for solid guarantees before entering Venezuela's volatile oil market. This demand ari...

Aclarion Inc. Posts Robust Growth in AI-Driven Diagnostic Platform as It Advances Toward 2026

Strong commercial adoption, ongoing clinical trials, and solid financial footing underpin Aclarion's upward momentum amid expanding market presence

Aclarion Inc. (NASDAQ:ACON) has reported significant gains in the deployment and clinical validation of its AI-powered diagnostic tool for chronic low...

U.S. Advances Massive Tariff Strategy to Deter Purchases of Russian Oil by Major Importers

Senate poised to consider legislation imposing steep tariffs to curb Russian energy sales benefiting Moscow’s war efforts

President Donald Trump has endorsed a bipartisan Senate initiative designed to impose a 500% tariff on countries importing Russian oil, with upcoming ...

Delta Air Lines' Q4 Earnings Preview: Analyst Ratings and Forecast Revisions Ahead of January Report

As Delta Air Lines gears up to announce its fourth-quarter earnings, several leading analysts adjust their outlooks, reflecting cautious optimism amid evolving market dynamics.

Delta Air Lines is set to release its Q4 earnings on January 13, 2026, with analysts projecting an increase in earnings per share and revenue compared...

Wall Street Revises Ratings: Airbnb Among Five Key Stock Upgrades on Thursday

Significant Analyst Rating Changes Highlight Optimism for Select Tech and Real Estate Stocks

Several influential Wall Street analysts have adjusted their recommendations on notable stocks, including Airbnb, Alphabet, and others, reflecting an ...